Source: EURLEX
Language: en
Format: md

|  |  |  |  |
| --- | --- | --- | --- |
| 20.3.2023 | EN | Official Journal of the European Union | C 104/40 |

---

Action brought on 1 February 2023 — Roche Diagnostics/EUIPO — SAS Di’X (AVENIO)

(Case T-34/23)

(2023/C 104/60)

Language in which the application was lodged: English

Parties

Applicant: Roche Diagnostics GmbH (Mannheim, Germany) (represented by: M. Douglas, lawyer)

Defendant: European Union Intellectual Property Office (EUIPO)

Other party to the proceedings before the Board of Appeal: SAS Di’X (Avignon, France)

Details of the proceedings before EUIPO

Proprietor of the trade mark at issue: Applicant before the General Court

Trade mark at issue: International registration designating the European Union in respect of the mark AVENIO — International registration designating the European Union No 1 313 134

Procedure before EUIPO: Opposition proceedings

Contested decision: Decision of the First Board of Appeal of EUIPO of 31 October 2022 in Case R 1291/2018-1

Form of order sought

The applicant claims that the Court should:

|  |  |
| --- | --- |
| — | annul the contested decision; |

|  |  |
| --- | --- |
| — | order EUIPO to pay the costs. |

Pleas in law

|  |  |
| --- | --- |
| — | Infringement of Article 95(1) of Regulation (EU) 2017/1001 of the European Parliament and of the Council; |

|  |  |
| --- | --- |
| — | Infringement of Article 8(1)(b) of Regulation (EU) 2017/1001 of the European Parliament and of the Council; |

|  |  |
| --- | --- |
| — | Infringement of Article 94(1) of Regulation (EU) 2017/1001 of the European Parliament and of the Council; |

|  |  |
| --- | --- |
| — | Incorrect assessment of the likelihood of confusion. |

---

[Top](#document1)